Promising drug for kids with rare muscle disease moves to next phase
NCT ID NCT06055959
First seen Jan 11, 2026 · Last updated May 19, 2026 · Updated 23 times
Summary
This study tests an investigational drug called zilucoplan in 8 children (ages 2-17) with generalized myasthenia gravis, a condition that causes muscle weakness. The goal is to see how the drug moves through the body, its safety, and whether it helps control symptoms. Participants receive the drug for several weeks, and researchers monitor side effects and changes in muscle function.
Disclaimer
Read more
Show less
This is a summary of
the original study
.
Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for GENERALIZED MYASTHENIA GRAVIS are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Study contacts
-
Contact
Phone: •••-•••-•••• Email: •••••@•••••
-
Contact
Phone: •••-•••-••••
Locations
-
Mg0014 20104
RECRUITINGSeoul, South Korea
-
Mg0014 20220
RECRUITINGSeoul, South Korea
-
Mg0014 40144
RECRUITINGMilan, Italy
-
Mg0014 40218
ACTIVE_NOT_RECRUITINGWarsaw, Poland
-
Mg0014 40735
RECRUITINGGlasgow, United Kingdom
-
Mg0014 40736
RECRUITINGLondon, United Kingdom
-
Mg0014 40774
RECRUITINGKatowice, Poland
-
Mg0014 50168
WITHDRAWNChicago, Illinois, 60611, United States
-
Mg0014 50574
WITHDRAWNDenton, Texas, 76208, United States
Conditions
Explore the condition pages connected to this study.